Koru Medical Systems, Inc. (KRMD) intrinsic value & 10-year financials
Koru Medical Systems, Inc. (KRMD) has a Graham intrinsic value of $0.32 per share. At $3.00 on Oct 17, 2026, the stock trades 838% above that value. Over the last 10 fiscal years revenue grew 14.4% a year to $41.1M, with an average return on invested capital of -26.7%.
- Graham intrinsic value
- $0.32
- Share price (Oct 17, 2026)
- $3.00
- Price vs Graham value
- 838% above
- Market cap
- $138.6M
- Revenue (FY2025)
- $41.1M
- Revenue growth (10-yr CAGR)
- 14.4%
- ROIC (10-yr avg)
- -26.7%
- Free cash flow (FY2025)
- -$470.1K
KRMD 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $41.1M | -$2.6M | -$0.06 | -$470.1K | -7.2% | -27.2% |
| FY2024 | $33.6M | -$6.1M | -$0.13 | -$1.6M | -19.2% | -54.8% |
| FY2023 | $28.5M | -$13.7M | -$0.30 | -$5.7M | -36.0% | -65.8% |
| FY2022 | $27.9M | -$8.7M | -$0.19 | -$8.2M | -38.6% | -58.2% |
| FY2021 | $23.5M | -$4.6M | -$0.10 | -$4.7M | -29.9% | -68.2% |
| FY2020 | $24.2M | -$1.2M | -$0.03 | -$1.7M | -5.2% | -17.3% |
| FY2019 | $23.2M | $564.3K | $0.01 | $119.4K | 2.5% | 8.5% |
| FY2018 | $17.4M | $910.6K | $0.02 | $1.2M | 6.7% | 11.5% |
| FY2017 | $12.3M | -$535.0K | -$0.01 | -$534.7K | -6.0% | -7.4% |
| FY2016 | $12.2M | $782.9K | $0.02 | $1.8M | 9.6% | 11.4% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
KORU Medical Systems, Inc. is a consistent compounder, expanding top-line revenue at 14.4% annually over the past decade.
KORU Medical Systems, Inc. has historically struggled to out-earn its cost of capital, averaging just -40.4% ROIC.
KORU Medical Systems, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, KORU Medical Systems, Inc. is modeled at 14.4% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.32 per share.